TCF7L2 and type 2 diabetes mellitus: For T2D, the top association in our study population, supported by both genotyped and imputed data, was in the region of BCL9. BCL9 encodes a protein that, along with TCF7L2, promotes beta-catenin’s transcriptional activity in the WNT-signaling pathway [81].